Advanced SearchNewsfeedFollowed Companies

Bristol Myers Squibb's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Bristol-Myers Squibb is a biopharmaceutical firm that discovers, develops and delivers medicines for patients prevail ov... Read more

Based on data from Bristol Myers Squibb's latest SEC filings

Annual Revenue

Based on data from Bristol Myers Squibb's latest SEC filings

Employees

Giovanni Caforio's photo - Chairman & CEO of Bristol Myers Squibb

Chairman & CEO

Giovanni Caforio

CEO Approval Rating

68/100

OVERVIEW

Founded:

1858

Headquarters:

New York, New York

Status:

PublicNYSEBMY

Industry Sector:

Pharmaceuticals,
Biotechnology

SIC Code:

2834NAICS listing »

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Amgen a competitor of Bristol Myers Squibb?

I don't know

Trending News for Bristol Myers Squibb and Bristol Myers Squibb's Competitors

April 7, 2020

Zacks

Bristol Myers/Acceleron's Reblozyl Label Expansion Gets FDA Nod

Bristol Myers (BMY) and Acceleron received FDA nod for the label expansion of Reblozyl for MDS patien... See more »

April 6, 2020

Reuters

UPDATE 2-GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln

British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate t... See more »

April 7, 2020

Pharamceutical Technology

Gilead signs drug discovery deal with Second Genome

Gilead Sciences has entered a multi-programme agreement with Second Genome to discover targets and dr... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Merck has been one of Bristol Myers Squibb's top competitors. Merck was founded in 1891, and is headquartered in Kenilworth, New Jersey. Merck competes in the Pharmaceuticals industry. Merck generates $20.7B more revenue vs. Bristol Myers Squibb.

Roche is a top competitor of Bristol Myers Squibb. Roche is a Public company that was founded in Basel, Basel-Country in 1896. Like Bristol Myers Squibb, Roche also competes in the Biotechnology industry. Roche has 74,700 more employees vs. Bristol Myers Squibb.

Gilead is perceived as one of Bristol Myers Squibb's biggest rivals. Gilead was founded in 1987, and its headquarters is in Foster City, California. Like Bristol Myers Squibb, Gilead also operates in the Pharmaceuticals field. Gilead has 11,500 fewer employees than Bristol Myers Squibb.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Giovanni Caforio

Chairman & CEO

- -
23,300
$0
$26.1B
1

Kenneth C. Frazier

Chairman & CEO

76/100
69,000
- -
$46.8B
2

Severin Schwan

CEO

66/100
3,700
- -
$898.3M
3

Daniel O’Day

Chairman & CEO

74/100
11,000
$86.3M
$22.4B
4

Albert Bourla

Chairman & CEO

81/100
92,400
- -
$51.8B
5

Robert A. Bradway

Chairman & CEO

69/100
19,200
$19M
$23.4B
6

Emma Walmsley

CEO

71/100
99,827
- -
$44.3B
7

Pascal Soriot

CEO

64/100
59,700
- -
$24.4B
8

David A. Ricks

Chairman & CEO

59/100
38,680
- -
$22.3B
9

Vasant Narasimhan

CEO

74/100
118,393
- -
$47.4B
10

Richard A. Gonzalez

Chairman & CEO

94/100
78
$3.8B
$33.3B
The top 10 competitors in Bristol Myers Squibb's competitive set are Merck, Roche, Gilead, Pfizer, Amgen, GSK, AstraZeneca, Eli Lilly, Novartis and AbbVie. Together they have raised over 3.9B between their estimated 620.1K employees. Bristol Myers Squibb has 23,300 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 48,661.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$26.1B

Bristol Myers Squibb's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 31.2B. Over the last four quarters, Bristol Myers Squibb's revenue has grown by 34.2%. Specifically, in Q4 2019's revenue was $7.9B; in Q3 2019, it was $6B; in Q2 2019, it was $6.3B; in Q1 2019, Bristol Myers Squibb's revenue was $5.9B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Celgene Corporation

Jan 2019

Source »
$74B
Celgene develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.
IFM Therapeutics, LLC

Aug 2017

Source »
$300M
IFM is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer and inflammatory disorders.
Cormorant Pharmaceuticals

Jul 2016

Source »
$500M
Cormorant Pharmaceuticals engages in the research and development of therapeutics for the treatment of cancer and rare diseases.
Padlock Therapeutics, Inc.

Mar 2016

Source »
$225M
Padlock Therapeutics researches, discovers, develops and commercializes drugs for protein arginine deiminases.
Cardioxyl Pharmaceuticals, Inc.

Nov 2015

Source »
$300M
Cardioxyl Pharmaceuticals engages in the discovery and development of therapies and technologies for the treatment of cardiovascular diseases.

These are all the companies that Bristol Myers Squibb has acquired. Bristol Myers Squibb has acquired 12 companies and its latest acquisition was Celgene Corporation in Jan 2019. Celgene develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Silverback is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and fibrosis.
$78.5M
Mar 10, 2020
Series B
-
GNS is an AI-based platform that offers drug modeling and intervention optimization solutions for the healthcare industry.
$5M
Jan 06, 2020
Series D
-
PathAI is an AI-based platform that develops pathology research solutions to treat and diagnose cancer and infectious diseases.
$15M
Nov 03, 2019
Series B
-
Vedanta is a biotechnology company that develops and commercializes novel therapies for the treatment of immune-mediated diseases.
$16.6M
Sep 10, 2019
Series C
-
Vedanta is a biotechnology company that develops and commercializes novel therapies for the treatment of immune-mediated diseases.
$18.5M
May 12, 2019
Series C
-

These are all the companies that Bristol Myers Squibb has invested in. Bristol Myers Squibb has invested 12 companies and its latest investment was Celgene Corporation in Jan 2019. Celgene develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.

Bristol Myers Squibb News

April 7, 2020Pharmabiz

US FDA approves erythroid maturation agent, Reblozyl to treat anemia in adults with lowerrisk MDS

Bristol Myers Squibb and Acceleron Pharma Inc, a biopharmaceutical company, announced the US Food and... See more »
April 6, 2020BioPortfolio

FDA approval for BMS and Acceleron's Reblozyl to reduce red blood cell transfusion dependence

The FDA has given the regulatory thumbsup in the US of Reblozyl luspaterceptaamt the first and only e... See more »
April 6, 2020Seeking Alpha

A Great Buy After The Pullback

See more »
April 3, 2020Seeking Alpha

FDA's OKs new use of Acceleron and Bristol-Myers Squibb's luspatercept

See more »
April 3, 2020FiercePharma

COVID-19 is bad news for new drug launches. Which will suffer most?

Amid the COVID-19 pandemic new drug rollouts, especially for chronic diseases, face an uphill fight, ... See more »
April 1, 2020FiercePharma

Gilead fails to overturn $752 million CAR-T patent verdict. Will BMS win case for larger penalties?

Bristol Myers Squibb scored a lucrative trial victory last year in a CAR-T patent squabble with Gilea... See more »
April 1, 2020FiercePharma

Good job on Celgene so far, but you'll have to work for your raise

Bristol Myers Squibb's top shareholders offered advice to the company as to how it should revise its ... See more »

Bristol Myers Squibb Press Releases

December 13, 2019O'Dwyer's PR News

Bristol-Myers Squibb Hires CVS' Metcalfe

Bristol-Myers Squibb has named healthcare PR veteran Kathryn Metcalfe executive VP, corporate affairs... See more »
December 7, 2019centralcharts

Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer

The Bristol-Myers Squibb-Pfizer Alliance today announced results from retrospective real-world data a... See more »
December 6, 2019GlobeNewswire

Young Investigators awarded $200k to study how the body's own defense mechanisms may be used in the fight against lung cancer

Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the Interna... See more »
September 11, 20191888 Press Release

Timothy Kocses, Director, Corporate Technical Accounting, Bristol-Myers Squibb Company to Speak at The Knowledge Group�s The New FASB Lease Accounting Standard

The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Ti... See more »
August 26, 2019Business Wire

Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) announced today that Celgene Corp... See more »
March 6, 2019streetinsider

Bristol-Myers Squibb to Take Part in the Barclays 2019 Global Healthcare Conference

Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the Barclays 2019 Globa... See more »
February 12, 2019CENTRALCHARTS

Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Celgene Corporation - CELG

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti... See more »

Bristol Myers Squibb Videos

June 27, 2019Bristol Myers Squibb Youtube Channel

"Strand Therapeutics on its Bristol-Myers Squibb LabCentral Golden Ticket Win" on YOUTUBE

See more »
May 12, 2019Bristol Myers Squibb Youtube Channel

"How May Using Biomarkers Help to Understand Rheumatoid Arthritis (RA)?" on YOUTUBE

See more »
April 30, 2019Bristol Myers Squibb Youtube Channel

"Cambridge: A Culture of Collaboration" on YOUTUBE

See more »
April 4, 2019Bristol Myers Squibb Youtube Channel

"Quality & Compliance | Biologics Careers at Devens, MA | Bristol-Myers Squibb" on YOUTUBE

See more »
January 25, 2019Bristol Myers Squibb Youtube Channel

"Making a Molecule" on YOUTUBE

See more »
January 7, 2019Bristol Myers Squibb Youtube Channel

"Running the Lab" on YOUTUBE

See more »
January 7, 2019Bristol Myers Squibb Youtube Channel

"Inclusion Through the Eyes of Our Leaders" on YOUTUBE

See more »

Social Statistics

Headquarters

430 E 29th Street 14th Floor

New York, New York10016

1-800-332-2056

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Bristol-Myers Squibb is a biopharmaceutical firm that discovers, develops and delivers medicines for patients prevail over serious diseases. Bristol Myers Squibb was founded in 1858. Bristol Myers Squibb's headquarters is located in New York, New York...

CEO

Bristol Myers Squibb's Chairman & CEO, Giovanni Caforio, currently has an approval rating of 68%. Bristol Myers Squibb's primary competitors are Merck, Roche & Gilead.

Website

bms.com

Frequently Asked Questions about Bristol Myers Squibb

  1. When was Bristol Myers Squibb founded?

    Bristol Myers Squibb was founded in 1858

  2. Who is Bristol Myers Squibb's CEO?

    Bristol Myers Squibb's CEO is Giovanni Caforio

  3. How much revenue does Bristol Myers Squibb generate?

    Bristol Myers Squibb generates $26.1B in revenue

  4. How much funding does Bristol Myers Squibb have?

    Bristol Myers Squibb has historically raised $0 in funding

  5. Where is Bristol Myers Squibb's headquarters?

    Bristol Myers Squibb's headquarters is in New York New York, USA

  1. How many employees does Bristol Myers Squibb have?

    Bristol Myers Squibb has 23,300 employees

  2. What sector does Bristol Myers Squibb operate in?

    Bristol Myers Squibb is in Pharmaceuticals, Biotechnology

  3. Who are Bristol Myers Squibb's competitors?

    Bristol Myers Squibb's top competitors are Merck, Roche, Gilead

  4. Who has Bristol Myers Squibb invested in?

    Bristol Myers Squibb's has invested in companies such as Silverback Therapeutics, GNS Healthcare, PathAI
Stay up-to-date with the latest news on Bristol Myers Squibb